Calidi Biotherapeutics (CLDI) Shares Issued (2022 - 2025)

Calidi Biotherapeutics has reported Shares Issued for 4 years, with the latest figure at $3.3 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Issued rose 1048.94% year-over-year to $3.3 million; the trailing twelve-month figure through Dec 2025 stood at $4.1 million (up 344.22% YoY), and the FY2025 full-year result was $3.3 million, up 4.78% from the prior year.
• Shares Issued for Q4 2025 stood at $3.3 million, up from $2000.0 in the prior quarter.
• The five-year high for Shares Issued was $3.3 million in Q4 2025, with the low at -$2.5 million in Q4 2023.
• Average Shares Issued over 4 years is $504888.9, with a median of $181000.0 recorded in 2023.
• Year-over-year, Shares Issued soared 2118.42% in 2023 and slumped 99.67% in 2025.
• Tracing CLDI's Shares Issued over 4 years: stood at $114000.0 in 2022, then plunged by 2274.56% to -$2.5 million in 2023, then jumped by 111.46% to $284000.0 in 2024, then jumped by 1048.94% to $3.3 million in 2025.
• The last three Shares Issued figures came in at $3.3 million (Q4 2025), $2000.0 (Q3 2025), and $284000.0 (Q4 2024), per Business Quant data.

Peer Comparison